Allogene to Present Positive Phase 1 Data for Investigational CAR T-cell Therapy ALLO-715
ALLO-715, an investigational donor-derived CAR T-cell therapy…
Myeloma
Myeloma overview
Myeloma is a rare blood cancer that begins in plasma cells, a type of white blood cell normally responsible for producing antibodies that help fight off infectious pathogens and other threats.
Read moreMyeloma treatment
While myeloma treatment can drive the disease into remission, sometimes for long periods of time, the cancer will often come back after a few months or years, and additional treatments will be needed.
Read moreLatest news
Radiation Therapy Safe for Myeloma Patients Before CAR T-cell Infusion, Study Finds
Administering radiation therapy to people with…
New Nirogacestat Combos to Enter Myeloma Trials, SpringWorks Says
SpringWorks Therapeutics announced new collaborations with two companies,…
Potential Cell Therapy for Multiple Myeloma Named Orphan Drug by FDA
The U.S. Food and Drug Administration (FDA) has…
No More Patients Needed in GENESIS Trial of Motixafortide, Committee Says
An independent data monitoring committee has recommended that the…
CLR 131 Elicits Promising Response Rates in Triple-refractory Multiple Myeloma Trial
CLR 131, Cellectar Biosciences’ lead experimental candidate,…
